Coverage
-
June 30, 2017
A Massachusetts federal judge on Friday granted Novartis Pharmaceuticals Corp.'s bid to toss a proposed class action alleging the company participated in an anti-competitive scheme to extend its monopoly on leukemia drug Gleevec.
6 other articles on this case.
View all »